APO Research
Talk to an analyst

APO RESEARCH · REPORT

Diammonium Glycyrrhizinate

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Diammonium Glycyrrhizinate Market Outlook and Growth Opportunities 2026

2 January 2026196 pages

Choose your research edition.

Industry ResearchDiammonium Glycyrrhizinate Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Diammonium Glycyrrhizinate Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Diammonium Glycyrrhizinate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diammonium Glycyrrhizinate Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Diammonium Glycyrrhizinate Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Diammonium Glycyrrhizinate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Diammonium Glycyrrhizinate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Diammonium Glycyrrhizinate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Diammonium Glycyrrhizinate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Diammonium Glycyrrhizinate market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Diammonium Glycyrrhizinate market include Chia Tai Tianqing Pharmaceutical Group Co. Ltd, Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd, Suzhou Erye Pharmaceutical Co. Ltd, Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd, Jiangsu Tiansheng Pharmaceutical Co. Ltd, Sinopharm Guorui Pharmaceutical Co. Ltd and ND Pharma & Biotech Co. Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Diammonium Glycyrrhizinate market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Diammonium Glycyrrhizinate and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Diammonium Glycyrrhizinate revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Diammonium Glycyrrhizinate market.

Diammonium Glycyrrhizinate Segment by Company

Chia Tai Tianqing Pharmaceutical Group Co. Ltd

Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd

Suzhou Erye Pharmaceutical Co. Ltd

Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd

Jiangsu Tiansheng Pharmaceutical Co. Ltd

Sinopharm Guorui Pharmaceutical Co. Ltd

ND Pharma & Biotech Co. Ltd.

Diammonium Glycyrrhizinate Segment by Type

Injection

Capsule

Diammonium Glycyrrhizinate Segment by Application

Chronic Viral Hepatitis

Immune Regulation

Diammonium Glycyrrhizinate Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Diammonium Glycyrrhizinate status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Diammonium Glycyrrhizinate key companies, revenue, market share, and recent developments.

3. To split the Diammonium Glycyrrhizinate breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Diammonium Glycyrrhizinate market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Diammonium Glycyrrhizinate significant trends, drivers, influence factors in global and regions.

6. To analyze Diammonium Glycyrrhizinate competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diammonium Glycyrrhizinate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diammonium Glycyrrhizinate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diammonium Glycyrrhizinate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Diammonium Glycyrrhizinate industry.

Chapter 3: Detailed analysis of Diammonium Glycyrrhizinate company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Diammonium Glycyrrhizinate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Diammonium Glycyrrhizinate in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Diammonium Glycyrrhizinate Industry Trends Table 2. Diammonium Glycyrrhizinate Industry Drivers Table 3. Diammonium Glycyrrhizinate Industry Opportunities and Challenges Table 4. Diammonium Glycyrrhizinate Industry Restraints Table 5. Global Diammonium Glycyrrhizinate Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Diammonium Glycyrrhizinate Revenue Share by Company (2021-2026) Table 7. Global Diammonium Glycyrrhizinate Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Diammonium Glycyrrhizinate Key Company Manufacturing Base & Headquarters Table 9. Global Diammonium Glycyrrhizinate Company, Product Type & Application Table 10. Global Diammonium Glycyrrhizinate Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Diammonium Glycyrrhizinate by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Injection Table 15. Significant Companies of Capsule Table 16. Global Diammonium Glycyrrhizinate Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Diammonium Glycyrrhizinate Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Diammonium Glycyrrhizinate Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Diammonium Glycyrrhizinate Sales Value Share by Type (2021-2026) Table 20. Global Diammonium Glycyrrhizinate Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Chronic Viral Hepatitis Table 22. Significant Companies of Immune Regulation Table 23. Global Diammonium Glycyrrhizinate Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Diammonium Glycyrrhizinate Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Diammonium Glycyrrhizinate Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Diammonium Glycyrrhizinate Sales Value Share by Application (2021-2026) Table 27. Global Diammonium Glycyrrhizinate Sales Value Share by Application (2027-2032) Table 28. Global Diammonium Glycyrrhizinate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Diammonium Glycyrrhizinate Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Diammonium Glycyrrhizinate Sales Value Share by Region (2021-2026) Table 31. Global Diammonium Glycyrrhizinate Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Diammonium Glycyrrhizinate Sales Value Share by Region (2027-2032) Table 33. Global Diammonium Glycyrrhizinate Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Diammonium Glycyrrhizinate Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Diammonium Glycyrrhizinate Sales Value Market Share by Country (2021-2026) Table 36. Global Diammonium Glycyrrhizinate Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Diammonium Glycyrrhizinate Sales Value Market Share by Country (2027-2032) Table 38. Chia Tai Tianqing Pharmaceutical Group Co. Ltd Company Information Table 39. Chia Tai Tianqing Pharmaceutical Group Co. Ltd Business Overview Table 40. Chia Tai Tianqing Pharmaceutical Group Co. Ltd Diammonium Glycyrrhizinate Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Chia Tai Tianqing Pharmaceutical Group Co. Ltd Diammonium Glycyrrhizinate Product Portfolio Table 42. Chia Tai Tianqing Pharmaceutical Group Co. Ltd Recent Development Table 43. Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Company Information Table 44. Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Business Overview Table 45. Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Product Portfolio Table 47. Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Recent Development Table 48. Suzhou Erye Pharmaceutical Co. Ltd Company Information Table 49. Suzhou Erye Pharmaceutical Co. Ltd Business Overview Table 50. Suzhou Erye Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Suzhou Erye Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Product Portfolio Table 52. Suzhou Erye Pharmaceutical Co. Ltd Recent Development Table 53. Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Company Information Table 54. Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Business Overview Table 55. Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Diammonium Glycyrrhizinate Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Diammonium Glycyrrhizinate Product Portfolio Table 57. Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Recent Development Table 58. Jiangsu Tiansheng Pharmaceutical Co. Ltd Company Information Table 59. Jiangsu Tiansheng Pharmaceutical Co. Ltd Business Overview Table 60. Jiangsu Tiansheng Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Jiangsu Tiansheng Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Product Portfolio Table 62. Jiangsu Tiansheng Pharmaceutical Co. Ltd Recent Development Table 63. Sinopharm Guorui Pharmaceutical Co. Ltd Company Information Table 64. Sinopharm Guorui Pharmaceutical Co. Ltd Business Overview Table 65. Sinopharm Guorui Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Sinopharm Guorui Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Product Portfolio Table 67. Sinopharm Guorui Pharmaceutical Co. Ltd Recent Development Table 68. ND Pharma & Biotech Co. Ltd. Company Information Table 69. ND Pharma & Biotech Co. Ltd. Business Overview Table 70. ND Pharma & Biotech Co. Ltd. Diammonium Glycyrrhizinate Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. ND Pharma & Biotech Co. Ltd. Diammonium Glycyrrhizinate Product Portfolio Table 72. ND Pharma & Biotech Co. Ltd. Recent Development Table 73. Research Programs/Design for This Report Table 74. Authors List of This Report Table 75. Secondary Sources Table 76. Primary Sources List of Figures Figure 1. Diammonium Glycyrrhizinate Product Image Figure 2. Global Diammonium Glycyrrhizinate Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Diammonium Glycyrrhizinate Market Size (2021-2032) & (US$ Million) Figure 4. Global Diammonium Glycyrrhizinate Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Injection Image Figure 8. Capsule Image Figure 9. Global Diammonium Glycyrrhizinate Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Diammonium Glycyrrhizinate Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Diammonium Glycyrrhizinate Sales Value Share by Type (2021-2032) Figure 12. Chronic Viral Hepatitis Image Figure 13. Immune Regulation Image Figure 14. Global Diammonium Glycyrrhizinate Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Diammonium Glycyrrhizinate Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Diammonium Glycyrrhizinate Sales Value Share by Application (2021-2032) Figure 17. Global Diammonium Glycyrrhizinate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Diammonium Glycyrrhizinate Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Diammonium Glycyrrhizinate Sales Value (2021-2032) & (US$ Million) Figure 20. North America Diammonium Glycyrrhizinate Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Diammonium Glycyrrhizinate Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Diammonium Glycyrrhizinate Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Diammonium Glycyrrhizinate Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Diammonium Glycyrrhizinate Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Diammonium Glycyrrhizinate Sales Value (2021-2032) & (US$ Million) Figure 26. South America Diammonium Glycyrrhizinate Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Diammonium Glycyrrhizinate Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Diammonium Glycyrrhizinate Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Capsule
Applications
  • Chronic Viral Hepatitis
  • Immune Regulation
Companies covered
  • Chia Tai Tianqing Pharmaceutical Group Co. Ltd
  • Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd
  • Suzhou Erye Pharmaceutical Co. Ltd
  • Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd
  • Jiangsu Tiansheng Pharmaceutical Co. Ltd
  • Sinopharm Guorui Pharmaceutical Co. Ltd
  • ND Pharma & Biotech Co. Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Diammonium Glycyrrhizinate Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Diammonium Glycyrrhizinate Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Diammonium Glycyrrhizinate Market Dynamics
  1. 2.1 Diammonium Glycyrrhizinate Industry Trends
  2. 2.2 Diammonium Glycyrrhizinate Industry Drivers
  3. 2.3 Diammonium Glycyrrhizinate Industry Opportunities and Challenges
  4. 2.4 Diammonium Glycyrrhizinate Industry Restraints
3 Diammonium Glycyrrhizinate Market by Company
  1. 3.1 Global Diammonium Glycyrrhizinate Company Revenue Ranking in 2025
  2. 3.2 Global Diammonium Glycyrrhizinate Revenue by Company (2021-2026)
  3. 3.3 Global Diammonium Glycyrrhizinate Company Ranking (2024-2026)
  4. 3.4 Global Diammonium Glycyrrhizinate Company Manufacturing Base and Headquarters
  5. 3.5 Global Diammonium Glycyrrhizinate Company Product Type and Application
  6. 3.6 Global Diammonium Glycyrrhizinate Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Diammonium Glycyrrhizinate Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Diammonium Glycyrrhizinate Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Diammonium Glycyrrhizinate Market by Type
  1. 4.1 Diammonium Glycyrrhizinate Type Introduction
  2. 4.1.1 Injection
  3. 4.1.2 Capsule
  4. 4.2 Global Diammonium Glycyrrhizinate Sales Value by Type
  5. 4.2.1 Global Diammonium Glycyrrhizinate Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Diammonium Glycyrrhizinate Sales Value by Type (2021-2032)
  7. 4.2.3 Global Diammonium Glycyrrhizinate Sales Value Share by Type (2021-2032)
5 Diammonium Glycyrrhizinate Market by Application
  1. 5.1 Diammonium Glycyrrhizinate Application Introduction
  2. 5.1.1 Chronic Viral Hepatitis
  3. 5.1.2 Immune Regulation
  4. 5.2 Global Diammonium Glycyrrhizinate Sales Value by Application
  5. 5.2.1 Global Diammonium Glycyrrhizinate Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Diammonium Glycyrrhizinate Sales Value by Application (2021-2032)
  7. 5.2.3 Global Diammonium Glycyrrhizinate Sales Value Share by Application (2021-2032)
6 Diammonium Glycyrrhizinate Regional Value Analysis
  1. 6.1 Global Diammonium Glycyrrhizinate Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Diammonium Glycyrrhizinate Sales Value by Region (2021-2032)
  3. 6.2.1 Global Diammonium Glycyrrhizinate Sales Value by Region: 2021-2026
  4. 6.2.2 Global Diammonium Glycyrrhizinate Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Diammonium Glycyrrhizinate Sales Value (2021-2032)
  7. 6.3.2 North America Diammonium Glycyrrhizinate Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Diammonium Glycyrrhizinate Sales Value (2021-2032)
  10. 6.4.2 Europe Diammonium Glycyrrhizinate Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Diammonium Glycyrrhizinate Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Diammonium Glycyrrhizinate Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Diammonium Glycyrrhizinate Sales Value (2021-2032)
  16. 6.6.2 South America Diammonium Glycyrrhizinate Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Diammonium Glycyrrhizinate Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Diammonium Glycyrrhizinate Sales Value Share by Country, 2025 VS 2032
7 Diammonium Glycyrrhizinate Country-level Value Analysis
  1. 7.1 Global Diammonium Glycyrrhizinate Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Diammonium Glycyrrhizinate Sales Value by Country (2021-2032)
  3. 7.2.1 Global Diammonium Glycyrrhizinate Sales Value by Country (2021-2026)
  4. 7.2.2 Global Diammonium Glycyrrhizinate Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Diammonium Glycyrrhizinate Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Diammonium Glycyrrhizinate Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Diammonium Glycyrrhizinate Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Chia Tai Tianqing Pharmaceutical Group Co. Ltd
  2. 8.1.1 Chia Tai Tianqing Pharmaceutical Group Co. Ltd Company Information
  3. 8.1.2 Chia Tai Tianqing Pharmaceutical Group Co. Ltd Business Overview
  4. 8.1.3 Chia Tai Tianqing Pharmaceutical Group Co. Ltd Diammonium Glycyrrhizinate Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chia Tai Tianqing Pharmaceutical Group Co. Ltd Diammonium Glycyrrhizinate Product Portfolio
  6. 8.1.5 Chia Tai Tianqing Pharmaceutical Group Co. Ltd Recent Developments
  7. 8.2 Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd
  8. 8.2.1 Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Company Information
  9. 8.2.2 Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Business Overview
  10. 8.2.3 Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Product Portfolio
  12. 8.2.5 Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Recent Developments
  13. 8.3 Suzhou Erye Pharmaceutical Co. Ltd
  14. 8.3.1 Suzhou Erye Pharmaceutical Co. Ltd Company Information
  15. 8.3.2 Suzhou Erye Pharmaceutical Co. Ltd Business Overview
  16. 8.3.3 Suzhou Erye Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Suzhou Erye Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Product Portfolio
  18. 8.3.5 Suzhou Erye Pharmaceutical Co. Ltd Recent Developments
  19. 8.4 Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd
  20. 8.4.1 Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Company Information
  21. 8.4.2 Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Business Overview
  22. 8.4.3 Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Diammonium Glycyrrhizinate Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Diammonium Glycyrrhizinate Product Portfolio
  24. 8.4.5 Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Recent Developments
  25. 8.5 Jiangsu Tiansheng Pharmaceutical Co. Ltd
  26. 8.5.1 Jiangsu Tiansheng Pharmaceutical Co. Ltd Company Information
  27. 8.5.2 Jiangsu Tiansheng Pharmaceutical Co. Ltd Business Overview
  28. 8.5.3 Jiangsu Tiansheng Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Jiangsu Tiansheng Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Product Portfolio
  30. 8.5.5 Jiangsu Tiansheng Pharmaceutical Co. Ltd Recent Developments
  31. 8.6 Sinopharm Guorui Pharmaceutical Co. Ltd
  32. 8.6.1 Sinopharm Guorui Pharmaceutical Co. Ltd Company Information
  33. 8.6.2 Sinopharm Guorui Pharmaceutical Co. Ltd Business Overview
  34. 8.6.3 Sinopharm Guorui Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sinopharm Guorui Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Product Portfolio
  36. 8.6.5 Sinopharm Guorui Pharmaceutical Co. Ltd Recent Developments
  37. 8.7 ND Pharma & Biotech Co. Ltd.
  38. 8.7.1 ND Pharma & Biotech Co. Ltd. Company Information
  39. 8.7.2 ND Pharma & Biotech Co. Ltd. Business Overview
  40. 8.7.3 ND Pharma & Biotech Co. Ltd. Diammonium Glycyrrhizinate Revenue and Gross Margin (2021-2026)
  41. 8.7.4 ND Pharma & Biotech Co. Ltd. Diammonium Glycyrrhizinate Product Portfolio
  42. 8.7.5 ND Pharma & Biotech Co. Ltd. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst